Medtronic to acquire EOFlow for $738m.

Medtronic, a medical device company, agreed to acquire EOFlow, a wearable insulin delivery pump manufacturer, for $738m. "We're thrilled to accelerate our next phase of growth with a partner like Medtronic who shares our goal of simplifying diabetes management to make life easier for the customers we serve. Together, we'll work to advance innovation in wearable insulin patch technology to expand our reach to more individuals around the world living with diabetes. With a global footprint in over 100 countries, ability to scale up manufacturing quickly, and advanced software and sensor capabilities, Medtronic is the ideal strategic partner for EOFlow," Jesse J. Kim, EOFlow Founder and CEO.